The global Pyrogen Testing market is anticipated to grow at a considerable CAGR of around 8.5%during the forecast period (2022-2028). The rising prevalence of infectious diseases such as HIV/AIDS, Infectious mononucleosis., Influenza (flu), Chickenpox, Common cold among others across the globe, respect to this the demand for pyrogen testing techniques that are utilized for endotoxin and microbial identification are propelling thereby boosting the pyrogen testing market growth. As per the U.S. Department of Health & Human Services, here were approximately 37.7 million people across the globe with HIV in 2020. Of these, 36 million were adults and 1.7 million were children aged 0-14 years. More than half (53%) were women and girls. In addition, as per Kaiser Family Foundation, Approximately 38 million people are currently living with HIV, and tens of millions of people have died of AIDS-related causes since the beginning of the epidemic. The prevalence is projected to drive the demand for the pyrogen testing kits to detect HIV immediately after infection, which in turn will accelerate the market growth.
Browse the full report description of “Global Pyrogen Testing Market Size, Share & Trends Analysis Report by Product &Services (Assays, Kits & Reagents, Instruments, and Services), By Test Type (LAL, Monocyte Activation, Chromogenic, Turbidimetric, Gel Clot, In Vitro, Rabbit, and Others), By End-User (Pharmaceutical companies, Biotechnology Companies, Medical Device Companies and, Others), Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/pyrogen-testing-market
A product such as an endotoxin identification product helps in improving the management of infectious diseases in areas with inadequate healthcare infrastructure. Pyrogen testing for it bacterial endotoxin is a key safety and quality issue for the pharmaceutical and medical device sectors. For instance, in October 2021- Fujifilm Wako Chemicals provided instruments for endotoxin testing including Toxinometer® ET-7000 it is a computer-operated kinetic incubating tube reader, that is designed to be exceptionally user-friendly. This system offers a high level of testing flexibility through its capability to perform all three LAL testing methods such as gel clot technique, kinetic turbidimetric, and kinetic chromogenic assays).
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product & Services
o By Test Type
o By End-User
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- BIOMÉRIEUX SA, Charles River Laboratories International, Inc., Ellab A/S, GenScript Biotech Corp., Lonza Group Ltd., MAT BioTech B.V., Merck KGaA, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global Pyrogen Testing Market Report Segment
By Product & Services
By Test Type
By End-User
Global Pyrogen Testing Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/pyrogen-testing-market